• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CLPT

CLPT

ClearPoint Neuro, Inc.

NASDAQHealthcareMedical - DevicesUS

USD13.30

+0.93 (+7.52%)

Rating:D+

Company Profile

CEO

Joseph Michael Burnett

IPO Date

2012-05-22

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$12.29

Prev. Close

$12.37

Day Low

$12.11

Day High

$13.48

52W Low

$8.27

52W High

$30.10

Market Cap

$0.40B

Volume

0.72M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

44.9%

Avg Negative

12.8%

Avg Neutral

42.7%

News Feed

ClearPoint Neuro Stock Dives After Q2 Earnings

Benzinga·8/11/2021·↑ positive

ClearPoint Neuro, Inc. (CLPT) CEO Joe Burnett on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/10/2021·↓ negative

ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Lags Revenue Estimates

Zacks Investment Research·8/10/2021·↑ positive

Recap: ClearPoint Neuro Q2 Earnings

Benzinga·8/10/2021·↓ negative

ClearPoint Neuro: Path To Being The Neurological Navigation Platform Company

Seeking Alpha·8/6/2021·↑ positive

ClearPoint Neuro, Inc. (CLPT) Stock Jumps 9.8%: Will It Continue to Soar?

Zacks Investment Research·7/26/2021·↑ positive

2 Stocks that could 10X in 10 years

The Dog of Wall Street·7/25/2021·↑ positive

Blackrock Neurotech, ClearPoint Neuro to Address Neurological Disorders With Novel Brain-Computer Interface Surgical Solution

GlobeNewsWire·7/21/2021·↑ positive

ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors

GlobeNewsWire·7/15/2021·↑ positive

ClearPoint Neuro, Inc. Announces Installation of ClearPoint® 2.0 Software at Mazowiecki Szpital Bródnowski in Poland

GlobeNewsWire·6/16/2021·↑ positive